View ValuationGivaudan 将来の成長Future 基準チェック /26Givaudan利益と収益がそれぞれ年間5.4%と3.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に22.3% 5.1%なると予測されています。主要情報5.4%収益成長率5.09%EPS成長率Chemicals 収益成長18.0%収益成長率3.9%将来の株主資本利益率22.27%アナリストカバレッジGood最終更新日01 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027お知らせ • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.お知らせ • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.お知らせ • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026お知らせ • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.お知らせ • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026お知らせ • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.お知らせ • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025お知らせ • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025お知らせ • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.お知らせ • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025お知らせ • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.お知らせ • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024お知らせ • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.お知らせ • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024お知らせ • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023お知らせ • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023お知らせ • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.業績と収益の成長予測OTCPK:GVDN.Y - アナリストの将来予測と過去の財務データ ( )CHF Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20288,2481,2471,1831,6771312/31/20277,8911,1711,1511,5951812/31/20267,5401,0641,0591,5151612/31/20257,4721,0711,2111,512N/A9/30/20257,5061,0831,1631,479N/A6/30/20257,5391,0941,1141,446N/A3/31/20257,4761,0921,2231,536N/A12/31/20247,4121,0901,3321,625N/A9/30/20247,2651,0611,3491,543N/A6/30/20247,1171,0321,3661,460N/A3/31/20247,0169631,2321,417N/A12/31/20236,9158931,0981,373N/A9/30/20236,9588799011,265N/A6/30/20237,0008657041,157N/A3/31/20237,0598616741,053N/A12/31/20227,117856644948N/A9/30/20227,040818676976N/A6/30/20226,9637807081,004N/A3/31/20226,8248018701,146N/A12/31/20216,6848211,0321,288N/A9/30/20216,5798161,0191,252N/A6/30/20216,4748111,0061,215N/A3/31/20216,3987779851,202N/A12/31/20206,3227439641,189N/A9/30/20206,3267399571,222N/A6/30/20206,3307359491,254N/A3/31/20206,2677198831,195N/A12/31/20196,2037028161,136N/A9/30/20196,075687N/A1,027N/A6/30/20195,947672N/A918N/A3/31/20195,737668N/A917N/A12/31/20185,527663N/A916N/A9/30/20185,385685N/A889N/A6/30/20185,242707N/A861N/A3/31/20185,147714N/A861N/A12/31/20175,051720N/A861N/A9/30/20174,932690N/A849N/A6/30/20174,812660N/A837N/A3/31/20174,738652N/A821N/A12/31/20164,663644N/A805N/A9/30/20164,605648N/A808N/A6/30/20164,546651N/A811N/A3/31/20164,471638N/A863N/A12/31/20154,396625N/A915N/A9/30/20154,397613N/A922N/A6/30/20154,397600N/A929N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: GVDN.Yの予測収益成長率 (年間5.4% ) は 貯蓄率 ( 3.5% ) を上回っています。収益対市場: GVDN.Yの収益 ( 5.4% ) US市場 ( 16.4% ) よりも低い成長が予測されています。高成長収益: GVDN.Yの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: GVDN.Yの収益 ( 3.9% ) US市場 ( 11.4% ) よりも低い成長が予測されています。高い収益成長: GVDN.Yの収益 ( 3.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: GVDN.Yの 自己資本利益率 は、3年後には高くなると予測されています ( 22.3 %)成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/07 00:13終値2026/05/07 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Givaudan SA 18 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。37 アナリスト機関Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchJames KnightBarclays34 その他のアナリストを表示
お知らせ • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027
お知らせ • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.
お知らせ • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.
お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.
お知らせ • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026
お知らせ • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.
お知らせ • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026
お知らせ • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.
お知らせ • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025
お知らせ • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025
お知らせ • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.
お知らせ • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025
お知らせ • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.
お知らせ • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024
お知らせ • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.
お知らせ • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024
お知らせ • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023
お知らせ • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023
お知らせ • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.